Skip to content

Author

Zhuldyz Myrzabay

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Venlafaxine in oncology: supportive-care evidence and emerging preclinical anticancer signals: a systematic review

Venlafaxine, a serotonin–norepinephrine reuptake inhibitor, has been investigated in oncology for several supportive care indications and, more recently, for potential anticancer activity. However, the available evidence remains fragmented across clinical and preclinical studies. This systematic review aimed...

Ahmad J. Harahsheh, Zhuldyz Myrzabay, Nazym Askambayeva et al. · 0 citations
Review Open access Oct 2026

Early Cardiac Biomarkers for the Detection of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer: A Systematic Review and Meta-Analysis

Background/Objectives: Chemotherapy-induced cardiotoxicity is a serious complication in breast cancer treatment, particularly with anthracyclines and HER2-targeted therapy. To evaluate the association between early elevations of cardiac markers (troponin and NT-proBNP) and the development of chemotherapy-induced cardio...

Nazym Askambayeva, Zhuldyz Myrzabay, Ahmad J. Harahsheh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.